Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users

by Marian Major, ALEXANDER GUTFRAIND, Louis Shekhtman, Qingwen Cui, Alla Kachko, Scott J. Cotler, Behzad Hajarizadeh, Rachel Sacks-Davis, Kimberly Page, Basmattee Boodram, Harel Dahari

Published in Science Translational Medicine by American Association for the Advancement of Science (AAAS).

2018 Volume 10, Issue 449, eaao4496

application/pdf 1.1 MB `file_7qnsef74a5a3bhoaaetiq5a4ji`
application/pdf 1.1 MB `file_3zs2phcimffkrfgcyzxhe4wx7a`	stm.sciencemag.org (publisher) web.archive.org (webarchive)

Preserved and Accessible

Type article-journal
Stage

published

Date 2018-07-11
Language en ^?

DOI 10.1126/scitranslmed.aao4496
PubMed 29997251

Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L: 1946-6234

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 5d6238fc-3dbb-4fd0-ab17-10b98690004f
API URL: JSON

Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users release_lzud2rwguzebpiqjrsl7hyvide